SUPERFLEX ASPHERIC
Report
- Report Number
- 3003563511-2014-00062
- Event Type
- Injury
- Date Received
- July 18, 2014
- Date of Event
- March 3, 2014
- Report Date
- June 12, 2014
- Manufacturer
- RAYNER INTRAOCULAR LENSES LIMITED
- Product Code
- HQL
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- IN
- Reporter Occupation
- PHYSICIAN
Narratives
RAYNER'S REVIEW OF PRODUCTION RECORDS FOR THE SUPERFLEX ASPHERIC 920H IOL BATCH 093E51185 SHOWED THAT ALL MANUFACTURING AND QUALITY CHECKS WERE CONDUCTED WITH SUCCESSFUL RESULTS. THERE ARE NO ISSUES ASSOCIATED WITH THE MANUFACTURE OF THESE BATCHES AND ALL STERILISATION ACTIVITIES WERE CARRIED OUT SUCCESSFULLY WITHOUT COMPLICATION. ALL DEVICES RELEASED FOR DISTRIBUTION FROM THE SUPERFLEX ASPHERIC 920H IOL BATCH 093E51185 WERE WITHIN TOLERANCE, MET SPECIFICATION CRITERIA AND WERE WITHOUT DEFECTS. THE BIOBURDEN AND ENDOTOXIN RESULTS FOR THE SUPERFLEX ASPHERIC 920H IOL BATCH 093E51185 WERE REVIEWED. THE BIOBURDEN RESULTS FOR THESE DEVICES WERE BELOW TARGET LEVEL AND THE ENDOTOXIN RESULTS WERE AT THE 0.5EU/DEVICE.
RAYNER INTRAOCULAR LENSES LIMITED RECEIVED NOTIFICATION FROM ITS (B)(4) DISTRIBUTOR OF AN EVENT THAT OCCURRED FOLLOWING IMPLANTATION OF A SUPERFLEX ASPHERIC 920H INTRAOCULAR LENS (IOL). THE EVENT DESCRIPTION PROVIDED STATES THAT ENDOPHTHALMITIS WAS OBSERVED IN THE POST-OPERATIVE PERIOD. FOR FURTHER INFO PLEASE REFER TO RAYNER INTRAOCULAR LENSES LIMITED'S MDR 9611165-2014-00062.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 423361 | SUPERFLEX ASPHERIC | HQL - INTRAOCULAR LENS | HQL | RAYNER INTRAOCULAR LENSES LIMITED | 920H | 093E51185 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Required Intervention | POST-OP GATIFLOXACILLIN WITH DEXAMETHASONE| VINCOMYCIN| AMIKACIN |